Browse > Article
http://dx.doi.org/10.4333/KPS.2010.40.2.091

Electrotransport of Donepezil Hydrochloride from Poly(ethylene oxide) Hydrogel  

Choi, Yu-Ri (College of Pharmacy, Sookmyung Women's University)
Oh, Seaung-Youl (College of Pharmacy, Sookmyung Women's University)
Publication Information
Journal of Pharmaceutical Investigation / v.40, no.2, 2010 , pp. 91-100 More about this Journal
Abstract
The objective of this work is to study transdermal delivery of donepezil hydrochloride (DH) using iontophoresis and to evaluate various factors which affect the transdermal transport. After the flux study using 4 kinds of hydrogel, hydrogel containing 8% poly(ethylene oxide) (PEO) was chosen as the hydrogel for further studies. Under experimental condition, DH was stable. We have studied the effect of polarity, current density, drug concentration and current profile on transdermal flux and compared the results. In vitro flux study was performed at $33^{\circ}C$, using side-by-side diffusion cell and full thickness hairless mouse skin. DH is positively charged at pH 7.4, and anodal delivery was much larger than cathodal and passive delivery at all current densities studied (0.2, 0.4 and 0.6 mA/$cm^2$). Cathodal delivery showed higher flux than passive flux. Flux increased as the concentration of DH in hydrogel increased. Pulsatile application of current showed smaller flux value than the application of continuous current. Based on these results, we have evaluated the possibility of delivering enough amount of DH to reach the therapeutic level. The maximum cumulative amount of DH transported for 12 hours was 455 ${\mu}g/cm^2{\cdot}hr$ when the amount of DH in the hydrogel was 3 mg/mL and the current density was 0.4 mA/$cm^2$. If the patch size is 10 $cm^2$, then we can deliver 4.6 mg for 12 hours. Because the daily dosage of DH is 5 mg, it seems possible to deliver clinically effective amount of DH using iontophoresis. This study also provides some information about the role of electrorepulsion and electroosmosis during the transport through skin.
Keywords
Iontophoresis; donepezil hydrochloride; hydrogel; Alzheimer's disease; electrorepulsion;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 J.H. Jhoo, K.W. Kim, Y. Huh, S.B. Lee, J.H. Park, J.J. Lee, E.A. Choi, C. Han, I.H. Choo, J.C. Youn, D.Y. Lee and J.I. Woo. Prevalence of dementia and its subtypes in an elderly urban Korean population: results from the Korean Longitudinal Study on Health And Aging (KLoSHA), Dement. Geriatr. Cogn. Disord., 26(3), 270-276 (2008).   DOI
2 R. Brookmeyer, E. Johnson, K. Ziegler-Graham and H.M. Arrighi, Forecasting the global burden of Alzheimer's disease, Alzheimers Dement., 3(3), 186-191 (2007).   DOI
3 E. England, Improving the management of dementia. BMJ, 332(7543), 681-682 (2006).   DOI
4 H.W. Querfurth and F.M. LaFerla, Alzheimer's Disease, N. Engl. J. Med., 362, 329-344 (2010).   DOI
5 P.T. Francis, A.M. Palmer, M. Snape and G.K. Wilcock, The cholinergic hypothesis of Alzheimer's disease: a review of progress, J. Neurol. Neurosurg. Psychiatry., 66(2), 137-147 (1999).   DOI
6 S.L. Rogers, R.S, Doody, R.C. Mohs and L.T. Friedhoff, Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebocontrolled study, Arch. Intern. Med., 158(9), 1021-1031 (1998).   DOI
7 N. Giladi, H. Shabtai, T. Gurevich, B. Benbunan, M. Anca and A.D. Korczyn, Rivastigmine (Exelon) for dementia in patients with Parkinson's disease, Acta. Neurol. Scand., 108(5), 368-373 (2003).   DOI
8 A.Z. Ables, Memantine (Namenda) for moderate to severe Alzheimer's disease, Am. Fam. Physician, 69(6), 1491-1492 (2004).
9 B. Winblad, J. Cummings, N. Andreasen, G. Grossberg, M. Onofrj, C. Sadowsky, S. Zechner, J. Nagel and R. Lane, A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's diseaserivastigmine patch versus capsule, Int. J. Geriatr. Psychiatry, 22(5), 456-467 (2007).   DOI
10 D.P. Reiss, Physician's Desk Reference, 53th ed, Montvale : Medical Economics Company, 2364-2367 (1999).
11 M.L. Crismon, Pharmocokinetics and drug interaction of cholinesterase inhibitors administered in Alzheimer’s disease, Pharmacotherapy, 18(2Pt2), 47-54 (1988).
12 F.E. Bailey Jr. and J.V. Koleske, poly (ethylene oxide), Academic Press, New York, U.S.A. (1976).
13 J.Y. Fang, K.C. Sung, H.H. Lin and C.L. Fang, Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies, Int J Pharm., 178(1), 83-92 (1999).   DOI
14 B. Langer, New methods of drug delivery, Science, 249(4976), 1527-1533 (1990).   DOI
15 M.D. Blanco, O. Garca, R. Olmo, J.M. Teijon and I. Katime, Release of 5-fluorouracil from poly (acrylamide-comonopropyl itaconate) hydrogels, J. Chromatogr. B. Biomed. Appl., 680, 243-253 (1996).   DOI
16 F.G. Hutchinson, Medical and pharmaceutical applications of water-soluble polymers : In Chemistry and Technology of water-soluble polymers, C.A. Finch (Ed.), Plenum Press, New York, U.S.A., 267-285 (1983).
17 N.B. Graham, Poly (ethylene oxide) and related hydrogels : In Hydrogels in Medicine and Pharmacy, Vol11, N.A. Peppas (Ed.), CRC Press, Boca Raton, U.S.A., 95-113 (1987).
18 R.S. Upasani and A.K. Banga, Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride. Pharm. Res., 21(112), 2293-2299 (2004).   DOI
19 S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher and K.H. Ashe, A specific amyloid-beta protein assembly in the brain impairs memory, Nature, 440(7082), 352-357 (2006).   DOI   ScienceOn
20 C. Zhao, W. Deng and F.H. Gage. Mechanisms and functional implications of adult neurogenesis, Cell, 132(4), 645-660 (2008).   DOI
21 T. Kankkunen, R. Sulkava, M. Vuorio, K. Kontturi and J. Hirvonen, Transdermal iontophoresis of tacrine in vivo, Pharm. Res., 19(5), 704-707 (2002).
22 A. Kim, P.G. Green, G.Rao and R.H. Guy, Convective solvent flow across the skin during iontophoresis, Pharm. Res., 10(9), 1315-1320 (1993).   DOI
23 D. Marro, R.H. Guy and M.B. Delgado-Charro, Characterization of the iontophoretic permselectivity properties of human and pig skin, J. Control. Release., 70, 213-217 (2001).   DOI
24 R.H. Guy, Y.N. Kalia, M.B. Delgado-Charro, V. Merino, A. Lopez and D. Marro, Iontophoresis : electrorepulsion and electroosmosis, J. Control. Rel., 64, 129-132 (2000).   DOI
25 B.D. Bath, H.S. White and E.R. Scott, Visualization and analysis of electroosmotic in hairless mouse skin, Pharm. Res., 17(4), 471-475 (2000).   DOI
26 D. Marro, R.H. Guy, and M.B. Delgado-Charro, Characterization of the iontophoretic permselectivity properties of human and pig skin, J. Control. Release, 70, 213-217 (2001).   DOI
27 P.S. Kishnani, J.A. Sullivan, B.K. Walter, G.A. Spiridigliozzi, P.M. Doraiswamy and K.R. Krishnan, Cholinergic therapy for Down’s syndrome, Lancet, 353(9158), 1064-1065 (1999).   DOI
28 Y.W. Chien and C.S. Lee, In Controlled Release Technology: Pharmaceutical Applications (Ed. P.I. Lee and W.R. Good), J. Am. Chem. Soc., Washington DC, chapter 21 (1987).
29 S.L. Rogers and L.T. Friedhoff, The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebo-controlled study, Dementia, 7(6), 293-303 (1996).
30 H. Choi (Ed.), Transdermal dosage form, Shinil publication, 136-138 (1999).
31 Y.N. Kalia, A. Naik, J. Garrison and R.H. Guy, Iontophoretic drug delivery, Adv. Drug Deliv. Rev., 56(5), 619-658 (2004).   DOI
32 S.A. Jung, H.S. Gwak, I.K. Chun and S.Y. Oh, Levodopa transport through skin using iontophoresis: the role of electroosmosis and electrorepulsion, J. Kor. Pharm. Sci., 38(1), 31-38 (2008).
33 J.E. Riviere and M.C. Heit, Electrically-assisted transdermal drug delivery, Pharm. Res., 14(6), 687-697 (1997).   DOI
34 S. Oh, Effect of formulation additives on the electroosmosis during iontophoresis, Abrtracts, The fifth asian international symposium on biomaterials, Biomaterial society of China, p. 308 (2006).
35 O.D. Uitto and H.S. White, Electroosmotic pore transport in human skin, Pharm. Res., 20(4), 646-652 (2003).   DOI
36 V. Merino, A. Lopez, Y.N. Kalia and R.H. Guy, Electrorepulsion versus electroosmosis : effect of pH on the iontophoresis flux of 5-fluorouracil, Pharm. Res., 16(5), 758-761 (1999).   DOI
37 J. Hirvonen and R.H. Guy, Transdermal iontophoresis: modulation of electroosmosis by polypeptides, J. Control. Release, 50, 283-289 (1998).   DOI
38 P.C. Kuo, Kinetics of transdermal permeation of oxycodone HCl and the enhancement by iontophoresis, M. Sc. thesis, Rutgers University, New Brunswick, N J.
39 R.R. Burnette and T.M. Bagniefski, Influence of constant current iontophoresis on the impedance and passive Na+ permeability of excised mouse skin, J. Pharm. Sci., 77(6), 492-497 (1988).   DOI
40 J.C. Liu, Y. Sun, O. Siddiqui, Y.W. Chien, W. M. Shi and J. Li, Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin, Int. J. Pharma., 44, 197-204 (1988).   DOI